IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12,122,660 | -27.5% | 308,151 | -55.1% | 2.13% | -38.4% |
Q1 2023 | $16,710,696 | -3.4% | 686,835 | -15.0% | 3.45% | -7.2% |
Q4 2022 | $17,300,158 | +19.3% | 808,041 | 0.0% | 3.72% | +10.1% |
Q3 2022 | $14,496,000 | +49.2% | 808,041 | -20.0% | 3.38% | +30.5% |
Q2 2022 | $9,717,000 | -54.3% | 1,010,051 | -20.0% | 2.59% | -51.6% |
Q1 2022 | $21,249,000 | +0.7% | 1,262,551 | 0.0% | 5.35% | +30.6% |
Q4 2021 | $21,110,000 | -11.1% | 1,262,551 | -13.7% | 4.10% | +9.9% |
Q3 2021 | $23,756,000 | +77.1% | 1,462,834 | -31.2% | 3.73% | +125.1% |
Q2 2021 | $13,411,000 | -8.5% | 2,125,371 | -10.4% | 1.66% | -38.8% |
Q1 2021 | $14,664,000 | -10.6% | 2,372,476 | 0.0% | 2.70% | +64.0% |
Q4 2020 | $16,396,000 | -13.7% | 2,372,476 | -29.6% | 1.65% | -68.9% |
Q3 2020 | $19,009,000 | +10.6% | 3,370,478 | 0.0% | 5.30% | -4.1% |
Q2 2020 | $17,189,000 | +479.3% | 3,370,478 | +290.8% | 5.53% | +223.8% |
Q1 2020 | $2,967,000 | -50.6% | 862,552 | +23.2% | 1.71% | -40.7% |
Q4 2019 | $6,006,000 | – | 700,000 | – | 2.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |